| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $216.1M | +8.7% |
| R&D Expense | $109.3M | +46.8% |
| SG&A Expense | $238.0M | +62.5% |
| Operating Income | -$151.2M | -271.8% |
| Pre-tax Income | -$138.6M | -504.9% |
| Income Tax | $81.8M | +2135.0% |
| Net Income | -$220.5M | -1066.5% |
| EPS (Basic) | -$3.74 | -1033.3% |
| EPS (Diluted) | -$3.74 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $84.9M | -17.1% |
| Accounts Receivable | $54.6M | +15.9% |
| Inventory | $1.9M | +7.3% |
| Current Assets | $347.3M | -20.9% |
| Total Assets | $488.9M | -25.5% |
| Current Liabilities | $145.2M | +45.2% |
| Total Liabilities | $161.8M | +37.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$109.4M | -594.6% |
| Capital Expenditures | $998K | +103.7% |
| Investing Cash Flow | $94.9M | +644.2% |
| Financing Cash Flow | -$2.9M | -1774.8% |
| Free Cash Flow | -$110.4M | -579.8% |
| -1033.3% |
| Stockholders' Equity |
| $327.2M |
| -39.2% |